This website is intended for healthcare professionals
Respiratory Handbook

The professional's guide to product selection

Kalydeco - Ivacaftor

Vertex

Description

A cystic fibrosis transmembrane conductance regulator (CFTR) protein potentiator that increases chloride transport in the abnormal CFTR protein.

By mouth using granules
Child 4–5 months (body-weight 5 kg and above): 25 mg every 12 hours.
Child 6 months–17 years (body-weight 5–6 kg): 25 mg every 12 hours.
Child 6 months–17 years (body-weight 7–13 kg): 50 mg every 12 hours.
Child 6 months–17 years (body-weight 14–24 kg): 75 mg every 12 hours.

By mouth using tablets
Child 6–17 years (body-weight 25 kg and above): 150 mg every 12 hours.
Adult: 150 mg every 12 hours – specialist use only.

Indications

A cystic fibrosis transmembrane conductance regulator (CFTR) protein potentiator that increases chloride transport in the abnormal CFTR protein.

Contraindications

Avoid use in pregnancy and when breast feeding. Use with caution in the case of renal or hepatic impairment. 

Preparations Available

Granules, Tablets

Sizes Available

Tablets
Kalydeco 75 mg, 28 tablets
Kalydeco 150 mg, 28 tablets
Kalydeco 150 mg, 56 tablets

More on: Mucolytics , Ivacaftor